Powered by OpenAIRE graph

Universiteit Twente, Faculty of Science and Technology (TNW), Fysische Scheidingen

Universiteit Twente, Faculty of Science and Technology (TNW), Fysische Scheidingen

2 Projects, page 1 of 1
  • Funder: Netherlands Organisation for Scientific Research (NWO) Project Code: KICH2.V4C.20.001

    In 2016 the 12-year program Fundamental Fluid Dynamics Challenges in Inkjet Printing (FIP) was started. In a consortium consisting of UT, TU/e and Canon Production Printing (Océ at the time) the first stage (FIP-I) was launched that will finish in 2022. The scientific goal of FIP is to gain more insight into the fluid dynamic challenges of the inkjet printing process to meet the demands of the future. Increasing resolution, speeding up the process, ink improvement and expansion of the field of applications are of great importance. The research focuses both on the processes in printhead and on the nozzle plate as well as on the processes on the substrate side. Insights from FIP I already resulted in improvements that could be readily applied at Canon Production Printing. This proposal concerns the second stage of the program, FIP II. The University of Utrecht will join the consortium. There will be additional attention to sustainable, environmentally friendly inks based on water as well as inks of more complex composition where the physicochemical hydrodynamics of droplets become essential. By means of experiments, theory and computer simulation the key physicochemical processes of the inkjet process will be studied. The fluid dynamics in the inkjet channel, the meniscus dynamics, droplet formation, jetting, droplet impact and spreading, droplet coalescence, droplet-film and droplet-paper interaction, and droplet evaporation and solidification will be studied.

    more_vert
  • Funder: Netherlands Organisation for Scientific Research (NWO) Project Code: NWA.1389.20.096

    NANOSPRESSO-NL specifically addresses the current mismatch between personalized therapeutic strategies and industrial centralized large-scale manufacture of medicines. The NANOSPRESSO-NL consortium is convinced that nucleic acid therapeutics are uniquely qualified for production in local hospital pharmacies in response to the needs of the individual patient. By switching towards a fully standardised platform formulation, quality control can be centred around the production process rather than the end product, quite similar to a popular method of decentralized high-quality espresso making.

    more_vert

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

Content report
No reports available
Funder report
No option selected
arrow_drop_down

Do you wish to download a CSV file? Note that this process may take a while.

There was an error in csv downloading. Please try again later.